div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documentoncoletter-cabozantinib-tki-targeting-vegf-receptors-met-axl-ret-improves-pfshtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: oncoletter · Cabozantinib TKI targeting VEGF receptors MET AXL RET Improves PFS in advanced renal cell carcinoma in 1st line vs sunitinibl and in 2nd line vs everolimus loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsinreader034viewer20220518106016838ab143192c713121f8html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documentoncoletter-cabozantinib-tki-targeting-vegf-receptors-met-axl-ret-improves-pfshtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: oncoletter · Cabozantinib TKI targeting VEGF receptors MET AXL RET Improves PFS in advanced renal cell carcinoma in 1st line vs sunitinibl and in 2nd line vs everolimus loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsinreader034viewer20220518106016838ab143192c713121f8html5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=documentoncoletter-cabozantinib-tki-targeting-vegf-receptors-met-axl-ret-improves-pfshtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: oncoletter · Cabozantinib TKI targeting VEGF receptors MET AXL RET Improves PFS in advanced renal cell carcinoma in 1st line vs sunitinibl and in 2nd line vs everolimus loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII=...